☆ 4.5 Letter

Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement

BONE MARROW TRANSPLANTATION (2019)

Journal

BONE MARROW TRANSPLANTATION

Volume 54, Issue 7, Pages 1148-1150

Publisher

NATURE PUBLISHING GROUP

DOI: 10.1038/s41409-019-0436-1

Keywords

-

Categories

Biophysics Oncology Hematology Immunology Transplantation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.